(R,S)N-Benzyl-4-hydroxy-2-(piperazin-1-yl)butanamide

ID: ALA1651899

PubChem CID: 51031624

Max Phase: Preclinical

Molecular Formula: C15H23N3O2

Molecular Weight: 277.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccccc1)C(CCO)N1CCNCC1

Standard InChI:  InChI=1S/C15H23N3O2/c19-11-6-14(18-9-7-16-8-10-18)15(20)17-12-13-4-2-1-3-5-13/h1-5,14,16,19H,6-12H2,(H,17,20)

Standard InChI Key:  UOQZXGVRRGDKLP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.6275   -7.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0842   -7.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0842   -8.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6275   -8.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3433   -7.7250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6275   -6.4875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8001   -7.3125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5160   -7.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2277   -7.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2277   -6.4875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5160   -6.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8001   -6.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3433   -8.5500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3433   -6.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3433   -5.2458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6275   -4.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6275   -4.0083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3433   -3.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0592   -4.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0592   -4.8333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  3  4  1  0
  1  5  2  0
  1  6  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 12  1  0
  2  7  1  0
  4 13  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 15 20  2  0
  6 14  1  0
M  END

Alternative Forms

Associated Targets(Human)

SLC6A11 Tchem GABA transporter 3 (176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A13 Tchem GABA transporter 2 (120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A1 Tclin GABA transporter 1 (308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Slc6a1 GABA transporter 1 (1980 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 277.37Molecular Weight (Monoisotopic): 277.1790AlogP: -0.04#Rotatable Bonds: 6
Polar Surface Area: 64.60Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.92CX LogP: -0.14CX LogD: -1.66
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.68Np Likeness Score: -0.73

References

1. Kulig K, Więckowski K, Więckowska A, Gajda J, Pochwat B, Höfner GC, Wanner KT, Malawska B..  (2011)  Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors.,  46  (1): [PMID:21111516] [10.1016/j.ejmech.2010.11.001]

Source